Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3735 3768 3791
This examiner grants 65% of resolved cases
Etsub D Berhanu is an examiner in Tech Center 3700 and Art Unit 3735, with 809 resolved cases contributing to these metrics. The allowance rate of 65.3 percent indicates a favorable environment for applicants, though it requires navigating a median days to allowance of 1302. This timeline suggests that while success is likely, the prosecution process is relatively lengthy compared to other units.
The interview lift of 24.8 percent is a significant factor for strategy development. This figure implies that applicants who engage in interviews are much more likely to secure an allowance compared to those who rely solely on written responses. Given the volume of 809 resolved cases, this lift represents a consistent trend that practitioners can leverage to accelerate or improve their prosecution outcomes. The data supports a proactive approach to communication to navigate the 1302 median days to allowance effectively.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17877867 | AUTONOMOUS SURGICAL SENSORS AND COMMUNICATION NETWORK | Final Rejection | Covidien LP |
| 18182630 | ATROPHY DETECTION FOR TISSUE OCCLUDED BY IMPLANTABLE INFLATION DEVICES | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18691486 | DATA GENERATION DEVICE, LEARNING SYSTEM, ESTIMATION SYSTEM, DATA GENERATION METHOD, AND RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 18821590 | SENSOR FOR DETECTING GLUCOSE AND LACTATE AND METHODS FOR DETERMINING AEROBIC AND ANAEROBIC THRESHOLDS | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 18784287 | ANALYTE MONITORING SYSTEM AND METHODS OF USE | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 18674805 | METHODS FOR INCORPORATING THERAPEUTIC AGENTS INTO ANALYTE SENSORS | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 18084944 | BED HAVING FEATURES TO PASSIVELY MONITOR BLOOD PRESSURE | Final Rejection | SNBR INC. |
| 18947053 | ANALYTE SENSOR MORPHOLOGY | Non-Final OA | Roche Diabetes Care, Inc. |
| 17759919 | Systems and Methods for Detection of Musculoskeletal Anomalies | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18692197 | PERSPIRATION ANALYSIS DEVICE AND METHOD | Non-Final OA | Nippon Telegraph and Telephone Corporation |
| 18488432 | ELECTROENCEPHALOGRAPHIC DATA ANALYSIS SYSTEM, INFORMATION PROCESSING TERMINAL, ELECTRONIC DEVICE, AND METHOD OF PRESENTING INFORMATION FOR DEMENTIA EXAMINATION | Non-Final OA | MAXELL, LTD. |
| 18615140 | EXPANDABLE INTRODUCER | Final Rejection | Medtronic, Inc. |
| 18496373 | NOTIFICATION INDICATIVE OF A CHANGE IN EFFICACY OF THERAPY | Final Rejection | Medtronic, Inc. |
| 16293325 | SYSTEM AND METHOD FOR MONITORING AND CONTROLLING A STATE OF A PATIENT DURING AND AFTER ADMINISTRATION OF ANESTHETIC COMPOUND | Final Rejection | The General Hospital Corporation |
| 18037117 | SYSTEM FOR SENSING EEG SIGNALS ON A LIVING BEING, AND SYSTEM FOR ELECTRICALLY STIMULATING TISSUE OF A LIVING BEING | Final Rejection | Precisis GmbH |
| 19064611 | CONTACTLESS MONITORING OF VITAL SIGNS USING ACCELEROMETER SIGNALS | Non-Final OA | Analog Devices International Unlimited Company |
| 18665034 | RAPID SAMPLING OF INTERSTITIAL FLUID USING A MICRONEEDLE ARRAY AND VACCUM-ASSISTED SKIN PATCH | Non-Final OA | William Marsh Rice University |
| 18727747 | USER-TRAINED SYSTEM | Final Rejection | TRINAMIX GMBH |
| 18717322 | BLOOD FLOW RESTRICTIVE CUFF WITH INTEGRATED BLOOD FLOW SENSOR | Non-Final OA | KCI Manufacturing Unlimited Company |
| 18696570 | APPARATUS AND METHOD FOR MEASURING PROPERTY OF EYE | Final Rejection | ICARE FINLAND OY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy